11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology

References

• Paliwal P, Hyman SM, Sinha R. Craving predicts time to cocaine relapse: further validation of the now and brief versions of the cocaine craving questionnaire. Drug Alcohol Depend. 2008;93:252–259. [PubMed: 18063320]
   PubMed Web of Science ®Google Scholar
• Sinha R, Garcia M, Paliwal P, et al. Stress-induced cocaine craving and hypothalamic-pituitary adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatr. 2006;63:324–331. [PubMed: 16520439]
   PubMed Web of Science ®Google Scholar
• Brandon TH, Vidrine JI, Litvin EB. Relapse and relapse prevention. Annu Rev Clin Psychol. 2007;3:257–284. [PubMed: 17716056]
   PubMed Web of Science ®Google Scholar
• Marlatt GA, Gordon JR. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press; 2007.
   Google Scholar
• Hendershot CS, Witkiewitz K, George WH, et al. Relapse prevention for addictive behaviors. Subst Abuse Treat Prev Policy. 2011;6:17.
   PubMed Web of Science ®Google Scholar
• Michael S. Listening to our clients: the prevention of relapse. J Psychoactive Drugs. 2008;40(2):167–172.
   Web of Science ®Google Scholar
• Ögel K, Guliyev C, Tekin K, et al. Development of the moodist relapse index scale. 11. National Alcohol Substance Addiction Congress; 2017.
   Google Scholar
• Gould TJ. Addiction and cognition. Addict Sci Clin Pract. 2010;5(2):4–14.
   PubMedGoogle Scholar
• Marlatt GA, Gordon JR. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press; 2007.
   Google Scholar
• Walsh R. Lifestyle and mental health. Am Psychol. 2011;66(7):579–592. doi: 10.1037/a0021769
   PubMed Web of Science ®Google Scholar
• Stephan KE, Bach DR, Fletcher PC, Flint J, Frank MJ, Friston KJ, Heinz A, Huys QJ, Owen MJ, Binder EB, Dayan P. Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis. The Lancet Psychiatry. 2016;3(1):77–83.
   PubMed Web of Science ®Google Scholar
• Veronese E, Castellani U, Peruzzo D, Bellani M, Brambilla P. Machine learning approaches: from theory to application in schizophrenia. Computational and mathematical methods in medicine. 2013.
   Web of Science ®Google Scholar
• Gheiratmand M, Rish I, Cecchi GA, Brown MR, Greiner R, Polosecki PI, Bashivan P, Greenshaw AJ, Ramasubbu R, Dursun SM. Learning stable and predictive network-based patterns of schizophrenia and its clinical symptoms. NPJ Schizophrenia. 2017;3(1):22.
   Google Scholar
• Çiftçi E, Kaya H, Güleç H, et al. The Turkish audio-visual bipolar disorder corpus. Proceedings of the 1st Asian Conference on Affective Computing and Intelligent Interaction (ACII Asia), AAAC; Beijing, China; 2018. p. 6.
   Google Scholar
• Kaya H, Gürpinar F, Afshar S, et al. Contrasting and combining least squares based learners for emotion recognition in the wild. Proceeding ACM ICMI; 2015. p. 459–466.
   Google Scholar
• Ringeval F, Schuller B, Valstar M, et al. AVEC 2018 workshop and challenge: bipolar disorder and cross-cultural affect recognition. 2018 Audio/Visual Emotion Challenge and Workshop (AVEC’18); 2018 Oct 22; Seoul (Republic of Korea). New York, NY (USA): ACM. p. 11.
   Google Scholar
• Hayes SC, Louma JB, Bond FW, et al. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006;44(1):1–25.
   PubMed Web of Science ®Google Scholar
• Orsillo SM, Batten, SV. Acceptance and commitment therapy in the treatment of posttraumatic stress disorder. Behav Modif. 2005;29(1):95–129.
   PubMed Web of Science ®Google Scholar
• Kashdan, Todd B, Kane JQ. Post-traumatic distress and the presence of post-traumatic growth and meaning in life: experiential avoidance as a moderator. Pers Indiv Differ. 2011;50(1):84–89.
   PubMed Web of Science ®Google Scholar
• Shalev AY, Freedman S, Peri T, et al. Prospective study of posttraumatic stress disorder and depression following trauma. Am J Psychiatr. 1998;155(5):630–637.
   PubMed Web of Science ®Google Scholar
• Hayes SC, et al. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006;44(1):1–25.
   PubMed Web of Science ®Google Scholar
• Orsillo SM., Batten SV. Acceptance and commitment therapy in the treatment of posttraumatic stress disorder. Behav Modif. 2005;29(1):95–129.
   PubMed Web of Science ®Google Scholar
• Follette VM, Ruzek JI, editors. Cognitive behavioral therapies for trauma. Ch 7. Guilford Press; 2007.
   Google Scholar
• Kearney DJ, Malte CA, McManus C, et al. Loving-kindness meditation for posttraumatic stress disorder: a pilot study. J Trauma Stress. 2013;26(4):426–434.
   PubMed Web of Science ®Google Scholar
• Au, TM, Sauer-Zavala S, King MW, et al. Compassion-based therapy for trauma-related shame and posttraumatic stress: initial evaluation using a multiple baseline design. Behav ther. 2017;48(2):207–221.
   Web of Science ®Google Scholar
• Bride BE. Prevalence of secondary traumatic stress among social workers. Social work. 2007;52(1):63–70.
   PubMed Web of Science ®Google Scholar
• Harris R. ACT made simple: an easy-to-read primer on acceptance and commitment therapy. New Harbinger Publications; 2009.
   Google Scholar
• Yavuz KF. Kabul ve Kararlılık Terapisi (ACT): Genel Bir Bakış. Turkiye Klinikleri Journal of Psychiatry Special Topics. 2015;8(2):21–27.
   Google Scholar
• Figley CR. Compassion fatigue as secondary traumatic stress disorder: an overview. In: CR Figley, editor. Compassion fatigue: coping with secondary traumatic stress disorder in those who treat the traumatised. New York: Brunner/Mazel Publishers; 1995. p. 1–20.
   Google Scholar
• Wang YM, Li N, Yang LL, et al. Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder. Psych Res. 2017;254:18–23.
   Web of Science ®Google Scholar
• Bauer M, Whybrow PC, Angst J, et al. World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiat. 2002;3:5–43.
   PubMedGoogle Scholar
• Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841–1853.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiat. 2006;163:1905–1917.
   PubMed Web of Science ®Google Scholar
• Wisniewski SR, Rush AJ, Nierenberg AA, et al. Can Phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiat. 2009;166:599–607.
   PubMed Web of Science ®Google Scholar
• Lisanby S, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34:522–534.
   PubMed Web of Science ®Google Scholar
• Brakemeier E-L, Luborzewski A, Danker-Hopfe H, et al. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiat Res. 2007;41:395–403.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Hoy KE, Anderson RJ, et al. A study of the pattern of response to rTMS treatment in depression. Depress Anxiety. 2016;33:746–753.
   PubMed Web of Science ®Google Scholar
• Rynn MA, Walkup JT, Compton SN, et al. Child/adolescent anxiety multimodal study: evaluating safety. J Am Acad Child Psy. 2015;54(3):180–190.
   Google Scholar
• Ginsburg G, Becker-Haimes E, Keeton C, Kendall PC. Results from the child/adolescent anxiety multimodal extended long-term study (CAMELS): primary anxiety outcomes. J Am Acad Child Psy. 2018;57(7):471–480.
   Google Scholar
• Zehgeer A, Ginsburg GS, Lee P, et al. Pharmacotherapy adherence for pediatric anxiety disorders: predictors and relation to child outcomes. Child Youth Care For. 2018;47(5):633–644.
   Web of Science ®Google Scholar
• Ak M, Sezlev D, Sutcigil L, Akarsu S, Ozgen F, Yanik T. Psychoneuroendocrinology. The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: olanzapine monotherapy. 2013;38(3):341–347.
   Google Scholar
• Reynolds GP, Kirk SL. Metabolic side effects of antipsychotic drug treatment–pharmacological mechanisms. Pharmacol Ther. 2010;125(1):169–179.
   PubMed Web of Science ®Google Scholar
• Parsons B, Allison DB, Loebel A, et al. Weight effects associated with antipsychotics: a comprehensive database analysis. Schizophr Res. 2009;110:103–110.
   PubMed Web of Science ®Google Scholar
• Goldberg, JF, Ernst CL. Managing the side effects of psychotropic medications. American Psychiatric Pub, 2018.
   Google Scholar
• Cooper SJ, Reynolds GP, Barnes T, et al. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. J Psychopharmacol. 2016;30(8):717–748.
   PubMed Web of Science ®Google Scholar
• Stroup, T. S., & Gray, N. Management of common adverse effects of antipsychotic medications. World Psychiatry, 2018;17(3):341–356.
   PubMed Web of Science ®Google Scholar
• Kelly K, Posternak M, Jonathan EA. Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci. 2008;10(4):409–418.
   PubMedGoogle Scholar
• Safer DJ, Zito JM. Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents. J Child Adolesc Psychopharmacol. 2006;16(1–2):159–169.
   PubMed Web of Science ®Google Scholar
• Isacsson G, Rich CL. Antidepressant drugs and the risk of suicide in children and adolescents. Pediatric Drugs. 2014:16(2);115–122.
   PubMed Web of Science ®Google Scholar
• Storebø OJ, Pedersen N, Ramstad E. et al. Methylphenidate for Attention-deficit/ hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomized studies. Cochrane Database of Systematic Reviews. 2018;5: Art. No.: CD012069
   Google Scholar
• Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgraduate Medicine. 2010;122 (1):184–191.
   PubMed Web of Science ®Google Scholar
• Selcen Yaroglu Kazanci, Mahmut Cem Tarakcioglu, Lida Bulbul, Neslihan Ozkul Saglam, Sami Hatipoglu. Should We Continue Methylphenidate Treatment Despite Orofacial or Extremity Dyskinesias? Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 2015;25(4):399–402.
   Web of Science ®Google Scholar
• Razoki B. Neurofeedback versus psychostimulants in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a systematic review. Neuropsychiatric disease and treatment. 2018;14:2905–2913.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhang J, Yuan Y, Cortese S. Effects of neurofeedback versus methylphenidate for the treatment of attention-deficit/hyperactivity disorder protocol for a systematic review and meta-analysis of head-to-head trials. Medicine. 2018;97(39):e12623.
   Web of Science ®Google Scholar
• Hudak J, Rosenbaum D, Barth B, Fallgatter AJ, Ehlis AC. Functionally disconnected: A look at how study design influences neurofeedback data and mechanisms in attention-deficit/hyperactivity disorder. PloS one. 2018;13(8):e0200931.
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. V ed. Washington (DC): American Psychiatric Association; 2013.
   Google Scholar
• Baio J, Wiggins L, Christensen DL, et al. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. Morbidity and mortality weekly report. Surveillance summaries. Washington, (DC: 2002). 2018;67(6):1–23.
   Google Scholar
• Rossignol DA. Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry. 2009;21:213–236.
   PubMed Web of Science ®Google Scholar
• Lubar JF, Shouse MN. EEG and behavioral changes in a hyperkinetic child concurrent with training of the sensorimotor rhythm (SMR): a preliminary report. Biofeedback Self Regul. 1976; 1:293–306.
   PubMedGoogle Scholar
• Fernandez T, Herrera W, Harmony T, et al. EEG and behavioral changes following neurofeedback treatment in learning disabled children. Clin Electroencephalogr. 2003;34:145–152.
   PubMedGoogle Scholar
• Fernandez T, Harmony T, Fernandez-Bouzas A, et al. Changes in EEG current sources induced by neurofeedback in learning disabled children. An exploratory study. Appl Psychophysiol Biofeedback. 2007;32:169–183.
   PubMed Web of Science ®Google Scholar
• Stone JH, Roberts M, O’Grady J, et al. Faulk’s basic forensic psychiatry. 3rd ed. Oxford: Blackwell Science; 1999.
   Google Scholar
• Gunn J, Taylor PJ. Forensic psychiatry: clinical, legal and ethical issues. 2nd ed. New York: CRC Press; 2014.
   Google Scholar
• Simon RI, Gold LH. The American psychiatric publishing textbook of forensic psychiatry. Washington (DC): American Psychiatric Publishing; 2004.
   Google Scholar
• Rogers R, Bagby RM, Chow MMK. Psychiatrists and the parameters of expert testimony. Int J Law Psychiatry. 1992;15(4):387–396.
   PubMed Web of Science ®Google Scholar
• Binder RL. Liability for the psychiatrist expert witness. Am J Psychiatry, 2002;159(11):1819–1825.
   Web of Science ®Google Scholar
• Stone JH, Roberts M, O’Grady J, et al. Faulk’s basic forensic psychiatry. 3rd ed. Oxford: Blackwell Science; 1999.
   Google Scholar
• Gunn J, Taylor PJ. Forensic psychiatry: clinical, legal and ethical issues. 2nd ed. New York: CRC Press; 2014.
   Google Scholar
• Salize HJ, Dreßing H, Peitz M. Compulsory admission and involuntary treatment of mentally ill patients-legislation and practice in EU-member states. Cent Inst Ment Heal Res Proj Final Report, Mannheim, Ger. 2002;15.
   Google Scholar
• Kallert TW. Coercion in psychiatry. Current opinion in psychiatry. 2008;21(5):485–489.
   PubMed Web of Science ®Google Scholar
• Coercive Treatment in Psychiatry: Clinical, Legal and Ethical Aspects. In Kallert TW, Mezzich JE, Monahan J, editors. Sussex: Wiley-Blackwell; 2011.
   Google Scholar
• Uygur N. Forensic psychiatry practical guide. 2nd ed. Psychiatric Association of Turkey [in Turkish]. Ankara: Pelin; 2014. p. 40–72.
   Google Scholar
• Comes et al. Transl Psychiatry. 2018;8:160.
   PubMedGoogle Scholar
• Ren et al. Psychoneuroendocrinology. 2017;86:17–24.
   PubMed Web of Science ®Google Scholar
• Assimakopoulos K, Karaivazoglou K, Skokou M, Kalogeropoulou M, Kolios P, Gourzis P, et al. Genetic Variations Associated with Sleep Disorders in Patients with Schizophrenia: A Systematic Review. Medicines. 2018;5:27.
   Google Scholar
• Chiua VW, Reec M, Jancab A, Iyyalold R, Dragovic M, et al. Sleep profiles and CBT-I response in schizophrenia and related psychoses. Psychiatry Research. 2018;268:279–287.
   Web of Science ®Google Scholar
• Van den Noort M, Bosch P. Schizophrenia and Sleep Disorders: An Introduction. Medicines. 2018;5:94.
   Google Scholar
• Sahbaz C, Özer OF, Kurtulmus A, Kırpınar I, Sahin F, et al. Evidence for an association of serum melatonin concentrations with recognition and circadian preferences in patients with schizophrenia. Metabolic Brain Disease. 2019. doi: 10.1007/s11011-019-00395-3
   Web of Science ®Google Scholar
• Kaskie R, Graziano B, Ferrarelli F. Schizophrenia and sleep disorders: links, risks, and management challenges. Nature and Science of Sleep. 2017;9:227–239.
   PubMed Web of Science ®Google Scholar
• Copps B, Yu C, Sylvestre JD, Segal M, Looper K, et al. Obstructive sleep apnea: underdiagnosed in older adults with severe mental illness? Sleep Breath. 2015;19:1407–1408.
   Web of Science ®Google Scholar
• Alam A, Chengappa R, Ghinassi F. Screening for obstructive sleep apnea among individuals with severe mental illness at a primary care clinic. General Hospital Psychiatry. 2012;34:660–664.
   PubMed Web of Science ®Google Scholar
• Malik P. Sexual dysfunction in schizophrenia. Curr Opin Psychiatry. 2007;20(2):138–142.
   Web of Science ®Google Scholar
• Hocaoglu C, Celik FH, Kandemir G, Guveli H, Bahceci B. Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study. Shanghai Arch Psychiatry. 2014;26(6):347–356.
   PubMedGoogle Scholar
• Cassidy RM, Yang F, Kapczinski F, Passos IC. Risk Factors for Suicidality in Patients with Schizophrenia: A Systematic Review, Meta-analysis, and Meta-regression of 96 Studies. Schizophr Bull. 2018;44(4):787–797. doi: 10.1093/schbul/sbx131
   PubMed Web of Science ®Google Scholar
• Hocaoglu C, Babuc ZT. Suicidal ideation in patients with schizophrenia. Isr J Psychiatry Relat Sci. 2009;46(3):195–203.
   PubMed Web of Science ®Google Scholar
• Fang X, Chen Y, Wang Y, Zhang C. Identification of risk factors for suicidal ideation in patients with schizophrenia. Psychiatry Res. 2018;271:195–199. doi: 10.1016/j.psychres.2018.11.051
   Web of Science ®Google Scholar
• Kim SW, Kim SJ, Mun JW, Bae KY, Kim JM, Kim SY, et al. Psychosocial factors contributing to suicidal ideation in hospitalized schizophrenia patients in Korea. Psychiatry Investig. 2010;7(2):79–85. doi: 10.4306/pi.2010.7.2.79
   Web of Science ®Google Scholar
• Marunkevych YY. Peculiarities of suicidal behavior of patients with paranoid schizophrenia with various clinical symptoms.Wiad Lek. 2018;71(7):1392–1397.
   Google Scholar
• Brotman MA, Kircanski K, Stringaris A, Pine DS, Leibenluft E. Irritability in youths: a translational model. American Journal of Psychiatry. 2017;174(6):520–532.
   PubMed Web of Science ®Google Scholar
• Peterson BS, Zhang H, Santa Lucia R, King RA, Lewis M. Risk factors for presenting problems in child psychiatric emergencies. Journal of the American Academy of Child & Adolescent Psychiatry. 1996;35(9):1162–1173.
   Web of Science ®Google Scholar
• AmericanPsychiatricAssociation. Diagnostic and statistical manual of mental disorders (DSM-5^®). American Psychiatric Pub; 2013.
   Google Scholar
• Althoff RR. Pediatric Irritability Comes of Age. Elsevier; 2018.
   Google Scholar
• Wiggins JL, Briggs-Gowan MJ, Estabrook R, Brotman MA, Pine DS, Leibenluft E, et al. Identifying clinically significant irritability in early childhood. Journal of the American Academy of Child & Adolescent Psychiatry. 2018;57(3):191–199. e2.
   PubMed Web of Science ®Google Scholar
• Vidal-Ribas P, Brotman MA, Valdivieso I, Leibenluft E, Stringaris A. The status of irritability in psychiatry: a conceptual and quantitative review. Journal of the American Academy of Child & Adolescent Psychiatry. 2016;55(7):556–570.
   PubMed Web of Science ®Google Scholar
• Karalunas SL, Fair D, Musser ED, Aykes K, Iyer SP, Nigg JT. Subtyping attention-deficit/hyperactivity disorder using temperament dimensions: toward biologically based nosologic criteria. JAMA psychiatry. 2014;71(9):1015–1024.
   Web of Science ®Google Scholar
• Harty SC, Gnagy EM, Pelham Jr WE, Molina BS. Anger-irritability as a mediator of Attention-deficit/ hyperactivity disorder risk for adolescent alcohol use and the contribution of coping skills. Journal of child psychology and psychiatry. 2017;58(5):555–563.
   Web of Science ®Google Scholar
• Gratz KL. Risk factors for and functions of deliberate self-harm: an empirical and conceptual review. Clin Psychol Sci Pract. 2003;10:192–205.
   Web of Science ®Google Scholar
• Klonsky ED. The functions of deliberate self-injury: a review of the evidence. Clin Psychol Rev. 2007;27:226–239.
   PubMed Web of Science ®Google Scholar
• Madge N, Hewitt A, Hawton K, et al. Deliberate self-harm within an international community sample of young people: comparative findings from the Child & Adolescent Self-harm in Europe (CASE) Study. Journal of Child Psychology and Psychiatry. 2008;49:667–677.
   PubMed Web of Science ®Google Scholar
• Owens D, Horrocks J, House A. Fatal and non-fatal repetition of selfharm – Systematic review. British Journal of Psychiatry. 2002;181:193–199.
   PubMed Web of Science ®Google Scholar
• Tuisku V, Pelkonen M, Karlsson L et al. Suicidal ideation, deliberate self-harm behavior and suicide attempts among adolescent outpatients with depressive mood disorders and comorbid axis I disorders. Eur Child Adolesc Psychiatry. 2006;15:199–206.
   PubMed Web of Science ®Google Scholar
• Nixon MK, Cloutier P, Jansson SM. Nonsuicidal self-harm in youth: a population-based survey. CMAJ. 2008;178:306–312.
   PubMed Web of Science ®Google Scholar
• Hawton K, Hall S, Simkin S, et al. Deliberate self-harm in adolescents: a study of characteristics and trends in Oxford, 1990–2000. J Child Psychol Psychiatry. 2003;44(8):1191–1198.
   PubMed Web of Science ®Google Scholar
• Portzky G, van Heeringen K. Deliberate self-harm in adolescents. Curr Opin Psychiatry. 2007;20(4):337–342.
   PubMed Web of Science ®Google Scholar
• Simeon D, Favazza AR. Self-injurious Behaviors: Phenomenology and Assessment. In: Simeon D, Hollander E, Editors. Self-injurious Behaviors: Assessment and Treatment. Washington (DC): American Psychiatric Press; 2001.
   Google Scholar
• Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry. 2012;69(12):1295–1303.
   PubMed Web of Science ®Google Scholar
• Goodman DW. The consequences of attention-deficit/hyperactivity disorder in adults. J Psychiatr Pract. 2007;13(5):318–327.
   PubMedGoogle Scholar
• Goodman DW. Clinical Presentation, Diagnosis and Treatment of Attention-deficit/ hyperactivity disorder (ADHD) in Older Adults. A Review of the Evidence and its Implications for Clinical Care. 2016.
   Google Scholar
• MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073–1086.
   PubMed Web of Science ®Google Scholar
• Jones CA, Watson DJG, Fone KCF. Animal models of schizophrenia. Br. J. Pharmacol. 2011;164(4):1162–1194.
   PubMed Web of Science ®Google Scholar
• Brennand KJ, Gage FH. Concise review: the promise of human induced plu- ripotent stem cell-based studies of schizophrenia. Stem Cells. 2011;29(12):371, 1915–1922.
   Web of Science ®Google Scholar
• Buxbaum JD, Sklar P. Human induced pluripotent stem cells: a new model for schizophrenia? Cell Stem Cell. 2011;8(5):461–462.
   Web of Science ®Google Scholar
• Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripo- tent stem cells. Nature. 2011;473(7346):221–225.
   PubMed Web of Science ®Google Scholar
• Malik N, Rao MS. A review of the methods for human iPSC derivation. Pluripotent Stem Cells. Springer; 2013. p. 23–33.
   Google Scholar
• Baker BL, Blacher J, Crnic KA, Edelbrock C. Behavior problems and parenting stress in families of three-year-old children with and without developmental delays. American Journal on Mental Retardation, 2002;107(6):433–444.
   PubMedGoogle Scholar
• Bronfenbrenner U, Morris PA. The ecology of developmental processes; 1998.
   Google Scholar
• Maclean MJ, Sims S, Bower C, Leonard H, Stanley FJ, O’Donnell M. Maltreatment risk among children with disabilities. Pediatrics. 2017;139(4):e20161817.
   PubMed Web of Science ®Google Scholar
• Gundersen HJG, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. Journal of Microscopy. 1987;147:229–263.
   PubMed Web of Science ®Google Scholar
• Kipanyula MJ, Sife AS. Global Trends in Application of Stereology as a Quantitative Tool in Biomedical Research. Biomed Res Int. 2018;13:1825697.
   Google Scholar
• Bas O, Acer N, Mas N, Karabekir HS, Kusbeci OY, Sahin B. Stereological evaluation of the volume and volume fraction of intracranial structures in magnetic resonance images of patients with Alzheimer’s disease. Ann Anat. 2009;191(2):186–195.
   Web of Science ®Google Scholar
• Perry JC, Pakkenberg B, Vann SD. Striking reduction in neurons and glial cells in anterior thalamic nuclei of older patients with Down syndrome. Neurobiol Aging. 2019;75:54–61.
   Web of Science ®Google Scholar
• Kodish I, McClellan JM. Early onset schizophrenia. In: Dulcan, MK, editors, Dulcan’s Textbook of Child and Adolescent Psychiatry, 2nd ed. Arlington: American Psychiatric Association Publishing; 2015. p. 389–402.
   Google Scholar
• Andreasen NC, Paradiso S, O’Leary DS. “Cognitive dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?. Schizophr Bull. 1998;24:203–218.
   PubMed Web of Science ®Google Scholar
• Moberget T, Doan NT, Kaufmann T et al. Cerebellar volume and cerebellocerebral structural covariancein schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls. Molecular Psychiatry. 2017:1–9.
   Web of Science ®Google Scholar
• Laidia C, d’Albisa M, Wessaf M, Linkef J, Phillips M, Delavest M, Bellivier F, Versace A, Almeida J, Sarrazin S, Poupon C, Le Dudal K, Daban C, Hamdani N, Leboyer M, Houenou J. Cerebellar Volume in Schizophrenia and Bipolar I Disorder with and without Psychotic Features. Acta Psychiatr Scand. 2015;131(3):223–233.
   Web of Science ®Google Scholar
• Andreasen NC, Flashman L, Flaum M et al.Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA. 1994;272:1763–1769.
   Web of Science ®Google Scholar
• Staal WG, Hulshoff Pol HE, Schnack HG, Hoogendoorn MLC, Jellema K, Kahn RS. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am. J Psychiatry. 2000;157:416–421.
   PubMed Web of Science ®Google Scholar
• Szeszko PR, Gunning-Dixon F, Ashtari M, Snyder PJ, Lieberman JA, Bilder RM. Reversed Cerebellar Asymmetry in Men with First-Episode Schizophrenia. Biol Psychiatry. 2003;53:450–459.
   PubMed Web of Science ®Google Scholar
• Johnson CP, Christensen GE, Fiedorowicz JG, et al. Alterations of the cerebellum and basal ganglia in bipolar disorder mood states detected by quantitative T1ρ mapping. Bipolar Disorders. 2018;20:381–390.
   Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry. 2000;48:458–466.
   PubMed Web of Science ®Google Scholar
• Baldaçara L, Nery-Fernandes F, Rocha M, et al. Is cerebellar volume related to bipolar disorder? Journal of Affective Disorders. 2011;135:305–309.
   Web of Science ®Google Scholar
• Lin K, Shao R, Lu R, et al. Resting-state fMRI signals in offspring of parents with bipolar disorder at the high-risk and ultra-high-risk stages and their relations with cognitive function. Journal of Psychiatric Research. 2018;98:99–106.
   Web of Science ®Google Scholar
• Rapoport M, van Reekum R, Mayberg H. The role of the cerebellum in cognition and behavior. J Neuropsychiatry Clin Neurosci. 2000;12:193–198.
   PubMed Web of Science ®Google Scholar
• Murphy JA, Sarris J, Byrne GJ. A review of the Conceptualization and Risk Factors Associated with Treatment-Resistant Depression. Depression Research and Treatment. 2017;2017.
   Google Scholar
• Conway CR, George MS, Sackeim HA. Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough. JAMA Psychiatry. 2017;74(1):9–10.
   PubMed Web of Science ®Google Scholar
• Kali A. Psychobiotics: An emerging probiotic in psychiatric practice. Biomedical Journal 2016;39:223–224.
   Web of Science ®Google Scholar
• Li Y, Hao Y, Fan F, Zhang B. The Role of Microbiome in Insomnia, Circadian Disturbance and Depression. Front. Psychiatry 2018;9:669. doi:10.3389/fpsyt.2018.00669.
   PubMed Web of Science ®Google Scholar
• Raybould HE. Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci Basic Clin. 2010;153:41–46. doi: 10.1016/j.autneu.2009.07.007
   PubMed Web of Science ®Google Scholar
• Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol. 2011; 17:3888–3898. doi: 10.3748/wjg.v17.i34.3888
   PubMed Web of Science ®Google Scholar
• Reynolds AC, Broussard J, Paterson JL, Wright KP, Ferguson SA. Sleepy, circadian disrupted and sick: Could intestinal microbiota play an important role in shift worker health? Molecular Metabolism 2017;6:12–13.
   Web of Science ®Google Scholar
• Turnbaugh, PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The Human Microbiome Project. Nature. 2007;449:804–810.
   PubMed Web of Science ®Google Scholar
• Evrensel A, Ceylan ME. Bağırsak beyin ekseni: Psikiyatrik bozukluklarda bağırsak mikrobiyotasının rolü. Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry. 2015;7(4):461–472.
   Google Scholar
• Kartalcı Ş. Şizofreni EtyolojisindeMikrobiyotanın Rolü. Psikiyatride Güncel Yaklaşımlar-CurrentApproaches in Psychiatry. 2018;10(2):255–268.
   Google Scholar
• Kuo P-H, Chung Y-CE. Moody microbiome: Challenges and chances. Journal of the Formosan Medical Association; 2018, doi: 10.1016/j.jfma.2018.09.004
   Web of Science ®Google Scholar
• Bruce-Keller AJ, Salbaum JM, Berthoud HR. Harnessing Gut Microbes for Mental Health: Getting from Here to There. Biological Psychiatry February 1. 2018;83:214–223.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhu G. Gut–Brain Axis and Mood Disorder. Front. Psychiatry. 2018;9:223. doi: 10.3389/fpsyt.2018.00223
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
   Google Scholar
• Glenn AL, Johnson AK, Raine A. Antisocial personality disorder: a current review. Curr Psychiatry Rep. 2013;15:427.
   PubMed Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Jama. 1990;264:2511–2518.
   PubMed Web of Science ®Google Scholar
• de Tribolet-Hardy F, Vohs K, Domes G, Regli D, Habermeyer E. [Violent offenders with or without antisocial personality disorder. A comparison]. Nervenarzt. 2011;82(1):43–49.
   PubMed Web of Science ®Google Scholar
• Howard R, McCarthy L, Huband N, Duggan C. Re-offending in forensic patients released from secure care: the role of antisocial/borderline personality disorder co-morbidity, substance dependence and severe childhood conduct disorder. Crim Behav Ment Health. 2013;23(3):191–202.
   Web of Science ®Google Scholar
• Palijan TZ, Radeljak S, Kovac M, Kovacević D. Relationship between comorbidity and violence risk assessment in forensic psychiatry - the implication of neuroimaging studies. Psychiatr Danub. 2010;22(2):253–256. Review.
   PubMed Web of Science ®Google Scholar
• Palmstierna T. [Personality disorders, violence and criminal behaviour]. Lakartidningen. 2016;113. pii:DY6R.
   Google Scholar
• Pondé MP, Caron J, Mendonça MS, Freire AC, Moreau N. The relationship between mental disorders and types of crime in inmates in a Brazilian prison. J Forensic Sci. 2014;59(5):1307–1314.
   PubMed Web of Science ®Google Scholar
• Black DW. The Natural History of Antisocial Personality Disorder. Can J Psychiatry. 2015;60(7):309–314.
   PubMed Web of Science ®Google Scholar
• Antisocial Personality Disorder: Treatment, Management and Prevention. Chapter II. The British Psychological Society & The Royal College of Psychiatrists; 2010.
   Google Scholar
• Goodwin D, Guze SB. Sociopathy (antisocial personality). In: Goodwin D, Guze SB, editors. Psychiatric diagnosis. 4th ed. New York (NY): Oxford University Press; 1989. p. 209–225.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
   Google Scholar
• Wong, C, et al. Evidence-Based Practices for Children, Youth, and Young Adults with Autism Spectrum Disorder. Autism Evidence-Based Practice Review Group Frank Porter Graham Child Development Institute University of North Carolina at Chapel Hill; 2014.
   Google Scholar
• Pickles, et al. Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomised controlled trial. The Lancet. 2016;388:2501–2509.
   PubMed Web of Science ®Google Scholar
• National Autistic Society. 2017. National Autism Project review. www.nationalautismproject.org.uk
   Google Scholar
• Tuzikow J, Holburn S. Identifying Fad Therapies for Autism Spectrum Disorders and Promoting Effective Treatment; 2011. p. 307–319.
   Google Scholar
• Metz B, Mulick JA, Butter EM. Autism: A late-20th-century fad magnet. Controversial therapies for developmental disabilities: Fad, fashion and science in professional practice; 2005.
   Google Scholar
• Zane T, Davis C, Rosswurm M. The cost of fad treatments in autism. Journal of Early and Intensive Behavior Intervention. 2008;5(2):44.
   Google Scholar
• Wiśniowiecka-Kowalnik B, Nowakowska BA. Genetics and epigenetics of autism spectrum disorder-current evidence in the field. J Appl Genet. 2019;60(1):37–47.
   PubMed Web of Science ®Google Scholar
• Vorstman JAS, Parr JR, Moreno-De-Luca D, Anney RJL, Nurnberger Jr JI, Hallmayer JF. Autism genetics: opportunities and challenges for clinical translation. Nat Rev Genet. 2017;18(6):362–376.
   Web of Science ®Google Scholar
• Woodbury-Smith M, Scherer SW. Progress in the genetics of autism spectrum disorder. Dev Med Child Neurol. 2018;60(5):445–451.
   PubMed Web of Science ®Google Scholar
• The Genetics of Pediatric-Onset Bipolar Disorder, 2003 Society of Biological Psychiatry. doi:10.1016/S0006-3223(02)01893-0
   Google Scholar
• Genetics of bipolar disorder, February 2014, The Application of Clinical Genetics: 33–42. doi:10.2147/TACG.S39297
   Google Scholar
• Neuroimaging biomarkers in bipolar disorder January 2012 Frontiers in bioscience (Elite edition) 4(2):593–606. doi:10.2741/40
   Google Scholar
• Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1:1106–1107.
   PubMed Web of Science ®Google Scholar
• Habib S, Hamid U, Jamil A, et al. Transcranial Magnetic Stimulation as a Therapeutic Option for Neurologic and Psychiatric Illnesses. Cureus. 2018;10(10):e3456.
   Web of Science ®Google Scholar
• Hayes SC, Villatte M, Levin M, Hildebrandt, M. Open, aware, and active: Contextual approaches as an emerging trend in the behavioral and cognitive therapies. Annual review of clinical psychology, 2011;7.
   Web of Science ®Google Scholar
• Harris R. ACT made simple: An easy-to-read primer on acceptance and commitment therapy. New Harbinger Publications; 2009.
   Google Scholar
• Yavuz KF. Kabul ve Kararlılık Terapisi (ACT): Genel Bir Bakış. Turkiye Klinikleri Journal of Psychiatry Special Topics. 2015;8(2):21–27.
   Google Scholar
• Correll CU, Carlson HE. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2006;45:771–791.
   PubMed Web of Science ®Google Scholar
• Jerrell JM, McInytre RS. Adverse events in children and adolescents treated with antipsychotic medications. Hum Psychopharmacol Clin Exp. 2008;23:283–290.
   PubMed Web of Science ®Google Scholar
• Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol. 2008;23(Suppl. 1):27–41.
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Zimmet P, Shaw J. Metabolic Syndrome. Diabetic Medicine, 2006;23:469–480.
   PubMed Web of Science ®Google Scholar
• Chen P-Y, Chen C-H, Chang CK, et al. Orexin-A levels in relation to the risk of metabolic syndrome in patient with schizophrenia taking antipsychotics. 2018; doi:10.1093/ijnp/pyy075
   Google Scholar
• Lappin JM, Wijaya M, Watkins A, et al. Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients. Schizophr. Res. 2018. https://doi.org/10.1016/j.schres.2018.02.035
   Web of Science ®Google Scholar
• McLaughlin, K. A., Koenen, K. C., Hill, E. D., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Kessler, R. C. (2013). Trauma exposure and posttraumatic stress disorder in a national sample of adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 52(8), 815–830.
   PubMed Web of Science ®Google Scholar
• Carrion, V. G., Weems, C. F., Watson, C., Eliez, S., Menon, V., & Reiss, A. L. (2009). Converging evidence for abnormalities of the prefrontal cortex and evaluation of midsagittal structures in pediatric posttraumatic stress disorder: an MRI study. Psychiatry Research: Neuroimaging, 172(3), 226–234.
   PubMed Web of Science ®Google Scholar
• Keding, T. J., & Herringa, R. J. (2015). Abnormal structure of fear circuitry in pediatric post-traumatic stress disorder. Neuropsychopharmacology, 40(3), 537.
   PubMed Web of Science ®Google Scholar
• McLaughlin, K. A., Busso, D. S., Duys, A., Green, J. G., Alves, S., Way, M., & Sheridan, M. A. (2014). Amygdala response to negative stimuli predicts PTSD symptom onset following a terrorist attack. Depression and anxiety, 31(10), 834–842.
   PubMed Web of Science ®Google Scholar
• Cohen, J. A., Bukstein, O., Walter, H., Benson, S. R., Chrisman, A., Farchione, T. R., Hamilton, J., Keable, H., Kinlan, J., Schoettle, U., Siegel, M., Stock, S., Medicus, J. Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder., 2010/04/23. 2010. p. 414–430.
   Google Scholar
• Fletcher KE. Childhood posttraumatic stress disorder. In: Barkley RA, Mash EJ, editors. Child Psychopathology. 2nd ed. New York: Guildford Press, 2003, 330–371.
   Google Scholar
• Gillies D, Taylor F, Gray C, O’Brien L, D’Abrew N. Psychological therapies for the treatment of post-traumatic stress disorder in children and adolescents. Evidence-based child health: a Cochrane review journal, 8(3), 1004–1116.
   Google Scholar
• Cohen, Judith A., Mannarino, Anthony P., ve Deblinger, Esther. Trauma-Focused CBT for Children And Adolescents Treatment Applications. New York: The Guildford Press, 2012, 1–29.
   Google Scholar
• Journal of The American Academy of Child & Adolescent Psychiatry (April 2010) Volume 49, Number 4.
   Google Scholar
• J. M. Smith, M. Silvestre, EMDR for the Next Generation-Healing Children and Families. 2nd ed., 2: 2014.
   Google Scholar
• National Institute for Clinical Excellence. Post-traumatic stress disorder (PTSD): The management of adults and children in primary and secondary care. London: NICE Guidelines; 2018.
   Google Scholar
• Shapiro, F. (1989). Eye movement desensitization: a new treatment for post-traumatic stress disorder. Journal of Behavior Therapy and Experimental Psychiatry, 20, 211–217.
   PubMed Web of Science ®Google Scholar
• Shapiro, F. (1995). Eye movement desensitization and reprocessing: basic principles protocols and procedures (1st ed.). New York: Guilford.
   Google Scholar
• Shapiro, F. (2001). Eye Movement Desensitization and Reprocessing: Basic Principles, Protocols, and Procedures (2nd ed.). New York: Guilford Press.
   Google Scholar
• Shapiro, E. Revue Européenne de Psychologie Appliquée 62 (2012): 241–251.
   Web of Science ®Google Scholar
• Berman, S.L., et al., The impact of exposure to crime and violence on urban youth. American Journal of Orthopsychiatry. 1996;66(3):329–336.
   PubMed Web of Science ®Google Scholar
• Keeshin, B.R., J.R. Strawn, Treatment of children and adolescents with posttraumatic stress disorder (PTSD): A review of current evidence. Child and Adolescent Psychopharmacology News. 2012;17(2):5–10.
   Google Scholar
• Cohen, J., The Work Group On Quality Issues ve AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 2010;49:414–430.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health; 2005.
   Google Scholar
• Scheeringa, M.S. and C.F. Weems, Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress. Journal of child and adolescent psychopharmacology. 2014;24(2):69–77.
   PubMed Web of Science ®Google Scholar
• Avni E, Ben-Itzchak E, Zachor DA. The presence of comorbid ADHD and anxiety symptoms in autism spectrum disorder: clinical presentation and predictors. Front Psychiatry. 2018;9:717.
   PubMed Web of Science ®Google Scholar
• Mahajan R, Bernal MP, Panzer R, et al. Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders. Pediatrics. 2012;130(Suppl. 2):125–138.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Shonka S, French WP, et al. Dose-response effects of long-acting liquid methylphenidate in children with attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD): A pilot study. J Autism Dev Disord. 2017;47(8):2307–2313.
   Web of Science ®Google Scholar
• Tumuluru RV, Corbett-Dick P, Aman MG, et al. Adverse events of atomoxetine in a double-blind placebo-controlled study in Children with Autism. J Child Adolesc Psychopharmacol. 2017;27(8):708–714.
   Web of Science ®Google Scholar
• Hızel C. Kanıta Dayalı, Öngörüsel ve Bireye Özgü Tıp Yeni Genetik ve Uygulamaları. İKU. 2010;24.
   Google Scholar
• Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 2008;392(6):1093–1108.
   PubMed Web of Science ®Google Scholar
• Bousman C, Al Maruf A, Müller DJ. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence based genetic testing panel. Current Opinion in Psychiatry. 2019;32(1):7–15.
   PubMed Web of Science ®Google Scholar
• Routhieaux M, Jessica J, Tillery EE. The use of pharmacogenetic testing in patients with schizophrenia or bipolar disorder: A systematic review. Ment Health Clin. 2018;8:294–302.
   Google Scholar
• Arıcıoğlu F, Çetin M. Psikiyatride Bireye Özgü Tedavi: Belki Biraz Eski Veya Biraz Yeni, Ama Geleceğin Tedavisi. Bulletin of Clinical Psychopharmacology. 2010;20:269–273.
   Google Scholar
• Goh LL, Lim CW, Sim WC, Toh LX, Leong KP. Analysis of genetic variation in CYP450 genes for clinical implementation. PLoS One 2017;12:e0169233.
   PubMed Web of Science ®Google Scholar
• Azuma J, Hasunuma T, Kubo M, Miyatake M, Koue T, Higashi K et al. The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine. Eur J Clin Pharmacol. 2012;68:29–37.
   PubMed Web of Science ®Google Scholar
• Zain MA, Jahan SN, Reynolds GP, Zainal NZ, Kanagasundram S, Mohamed Z. Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration. BMC Med Genet. 2012;13:91.
   Web of Science ®Google Scholar
• Shaw M, Hodgkin’s P, Caci H, Young S, Kahler J, Woods AG, Arnold LE A systematic review and analysis of long-term outcomes in Attention-deficit/ hyperactivity disorder: effects of treatment and non-treatment. BMC Medicine. 2012;10:99.
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J. Attention-Deficit/Hyperactivity Disorder: Diagnosis, Lifespan, Comorbidities, and Neurobiology. Journal of Pediatric Psychology. 2007;32(6):631–642.
   PubMed Web of Science ®Google Scholar
• AACAP (American Academy of Child and Adolescent Psychiatry) Practice Parameter for the Assessment and Treatment of Children and Adolescent with Attention-Deficit / Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.
   PubMed Web of Science ®Google Scholar
• Ercan ES, Avcı A, Mukaddes NM ve ark. Dikkat eksikliği ve hiperaktivite bozukluğu klinik uygulama kılavuzu, 2008, Türkiye.
   Google Scholar
• Vitiello B, Severe J. B, Greenhill LL, Arnold LE, Abikoff, HB, Bukstein OG, Cantwell DP. Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA. Journal of the American Academy of Child & Adolescent Psychiatry. 2001;40:188–196.
   PubMed Web of Science ®Google Scholar
• Everett CA, Everett SV. Family Therapy for ADHD: Treating Children, Adolescents, and Adults. Guilford Press; 2001. p. 1–10.
   Google Scholar
• Foley M. A comparison of family adversity and family dysfunction in families of children with Attention-deficit/ hyperactivity disorder (ADHD) and families of children without ADHD. Journal for Specialists in Pediatric Nursing. 2011;16(1):39–49.
   PubMed Web of Science ®Google Scholar
• Margari F, Craig F, Petruzzelli MG, Lamanna A, Matera E, Margari L. Parents psychopathology of children with Attention-deficit/ hyperactivity disorder. Res Dev Disabil. 2013;34(3):1036–1043. doi: 10.1016/j.ridd.2012.12.001
   PubMed Web of Science ®Google Scholar
• Wang CH, Mazursky-Horowitz H, Chronis-Tuscano A. Delivering Evidence-Based Treatments for Child Attention-Deficit/Hyperactivity Disorder (ADHD) in the Context of Parental ADHD. Psychiatry Rep. 2014;6(10):474. doi:10.1007/s11920-014-0474-8.
   Google Scholar
• Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013; 381: 1654–1662.
   PubMed Web of Science ®Google Scholar
• https://www.ebi.ac.uk/gwas/diagram
   Google Scholar
• Stahl EA, Forstner A, McQuillin A, et al. Genome wide association study identifies 30 loci associated with bipolar disorder. bioRxiv; 2017.
   Google Scholar
• Fries GR, Walss-Bass C, Bauer ME, et al. Revisiting inflammation in bipolar disorder. Pharmaco Biochem Behav. 2018;177:12–19. doi:10.1016/j.pbb.2018.12.006.
   Web of Science ®Google Scholar
• Barbosa IG, Machado-Vieira R, Soares JC, et al. The immunology of bipolar disorder. Neuroimmunomodulation. 2014;21(2–3):117–122. doi:10.1159/000356539. Epub 2014 Feb 14
   PubMed Web of Science ®Google Scholar
• Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiat Res. 2014;218(1–2):61–68. doi: 10.1016/j.psychres.2014.04.005
   PubMed Web of Science ®Google Scholar
• Tsitsipa E., Fountoulakis KN. The neurocognitive functioning in bipolar disorder: a systematic review of data. Tsitsipa and Fountoulakis Ann Gen Psychiatry 2015;14:42.
   PubMed Web of Science ®Google Scholar
• Demirel A, Demirel ÖF. Ötimik Bipolar Hastalarda Nörobilişsel Defisitler. Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry 2012;4(3):381–395.
   Google Scholar
• Lima IMM, Peckham AD, Johnson SL. Cognitive deficits in bipolar disorders: implications for emotion. Clin Psychol Rev. 2018;59:126–136. Epub 2017 Nov 21
   PubMed Web of Science ®Google Scholar
• Best MW, Bowie CR. Neurocognition and psychosocial functioning in adolescents with bipolar disorder. J Affect Disord. 2017;207:406–412.
   Web of Science ®Google Scholar
• Bora E. Neurocognitive features in clinical subgroups of bipolar disorder: a meta-analysis. J Affect Disord. 2018;229:125–134.
   PubMed Web of Science ®Google Scholar
• Halaris, Leonard B, editors. Neuroprogression in psychiatric disorders. Karger Verlag, Basel, 2017.
   Google Scholar
• Edberg D, Hoppensteadt D, Walborn A, et al. Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. J Psychiatr Res. 2018;102:1–7.
   PubMed Web of Science ®Google Scholar
• Ruiz NAL, Del Ángel DS, Olguín HJ, et al. Neuroprogression: the hidden mechanism of depression. Neuropsychiatr Dis Treat. 2018;14:2837–2845.
   Web of Science ®Google Scholar
• Clearfield MB. C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc. 2005;105(9):409–416.
   PubMedGoogle Scholar
• Deban L, Jaillon S, Garlanda C, et al. Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res. 2011;343:237–249.
   PubMed Web of Science ®Google Scholar
• Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009;71:171–186.
   PubMed Web of Science ®Google Scholar
• Rajan TM, Menon V. Psychiatric disorders and obesity: a review of association studies. J Postgrad Med. 2017;63(3):182–190.
   PubMed Web of Science ®Google Scholar
• Niego SH, Kofman MD, Weiss JJ, et al. Binge eating in the bariatric surgery population: a review of the literature. The Int J Eat Dis. 2007;40:349–359.
   PubMed Web of Science ®Google Scholar
• Gormally J, Black S, Daston S, et al. The assessment of binge eating severity among obese persons. Addictive Behaviors. 1982;7:47–55.
   PubMed Web of Science ®Google Scholar
• Rajan TM, Menon V. Psychiatric disorders and obesity: a review of association studies. J Postgrad Med. 2017;63(3):182–190.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing; 2013.
   Google Scholar
• Larkin D, Kirtchuk G, Yamaguchi M, et al. A proposal for the inclusion of ‘obesity dysmorphia’ in the diagnostic and statistical manual of mental disorders. Australian and New Zealand Journal of Psychiatry. 2017;51:1085–1086.
   Google Scholar
• Butchart A, Harvey AP. Preventing child maltreatment: a guide to taking action and generating evidence. Geneva: Switz: World Press; 2011.
   Google Scholar
• Fis NP, Arman A, Kalaca S, et al. Psychiatric evaluation of sexual abuse cases: a clinical representative sample from Turkey. Children and Youth Services Review. 2010;32(10):1285–1290.
   Web of Science ®Google Scholar
• Murray LK, Nguyen A, Cohen JA. Child sexual abuse. Child Adolesc Psychiatr Clin N Am. 2014;23(2):321–327.
   PubMed Web of Science ®Google Scholar
• Trickey D, Siddaway AP, Meiser-Stedman R, et al. A meta-analysis of risk factors for post-traumatic stress disorder in children and adolescents. Clin Psychol Rev. 2012;32(2):122–138.
   PubMed Web of Science ®Google Scholar
• Şimşek S. Level of cortisol and oxidative stress and DNA damage in child and adolescent victims of sexual abuse with or without PTSD. Bulletin of Clinical Psychopharmacology. 2015;25(Suppl 1):S22–S23.
   Google Scholar
• Fowler CJ, Doherty P, Alexander SPH. Endocannabinoid turnover. Adv Pharmacol. 2017;80:31–66. doi:10.1016/bs.apha.2017.03.006. Epub 2017 May 25. Review.
   Google Scholar
• Muccioli GG. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today. 2010;15(11–12):474–483. doi:10.1016/j.drudis.2010.03.007. Epub 2010 Mar 19. Review.
   PubMed Web of Science ®Google Scholar
• Wang J, Ueda N. Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat. 2009;89(3–4):112–119. doi:10.1016/j.prostaglandins.2008.12.002. Epub 2008 Dec 14. Review.
   PubMed Web of Science ®Google Scholar
• Basavarajappa BS. Critical enzymes involved in endocannabinoid metabolism. Protein Pept Lett. 2007;14(3):237–246. Review.
   PubMed Web of Science ®Google Scholar
• Alptekin M, Keser A. Relationship between endocannabinoid system, insulin resistance and fatty acids. Bes Diy Derg 2016:44(2):144–153.
   Google Scholar
• Fowler CJ, Doherty P, Alexander SPH. Endocannabinoid turnover. Adv Pharmacol. 2017;80:31–66.
   Google Scholar
• Muccioli GG. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today. 2010;15(11-12):474–483.
   PubMed Web of Science ®Google Scholar
• Wang J, Ueda N. Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat. 2009;89((3-4):112–119.
   PubMed Web of Science ®Google Scholar
• Basavarajappa BS. Critical enzymes involved in endocannabinoid metabolism. Protein Pept Lett. 2007;14(3):237–246.
   PubMed Web of Science ®Google Scholar
• Alptekin M, Keser A. Relationship between endocannabinoid system, insulin resistance and fatty acids. Bes Diy Derg. 2016;44(2):144–153.
   Google Scholar
• Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu. Rev. Psychol. 2013;64:21–47.
   PubMed Web of Science ®Google Scholar
• Ruehle S, Rey AA, Remmers F, et al. The endocannabinoid system in anxiety, fear memory and habituation. J. Psychopharmacol. 2012;26(1):23–39.
   PubMed Web of Science ®Google Scholar
• Morena M, Patel S, Bains JS, et al. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology. 2016;41(1):80–102.
   PubMed Web of Science ®Google Scholar
• Katzman MA, Furtado M, Anand L. Targeting the endocannabinoid system in psychiatric illness. J. Clin. Psychopharmacol. 2016;36(6):691–703.
   Web of Science ®Google Scholar
• Ibarra-Lecue I, Pilar-Cuellar F, Muguruza C, et al. The endocannabinoid system in mental disorders: evidence from human brain studies. Biochem Pharmacol. 2018.
   Web of Science ®Google Scholar
• Dekker JJM, Hendriksen M, Kool S, et al. Growing evidence for psychodynamic therapy for depression. Contemporary Psychoanalysis. 2014;50(1-2):131–155.
   Web of Science ®Google Scholar
• Fonagy P. The effectiveness of psychodynamic psychotherapies: an update. World Psychiatry. 2015;14:137–150.
   PubMed Web of Science ®Google Scholar
• Driessen E, Van HL, Don FJ, et al. The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial. Am J Psychiatry. 2013;170:1041–1050.
   PubMed Web of Science ®Google Scholar
• Gillam S, Kamhi A. Specific language impairment. In: M Ball, J Damico, N Mueller, editors. Blackwell Handbook in linguistics: the handbook of language and speech disorders. Hoboken, NJ: Wiley-Blackwell; 2010.
   Google Scholar
• Paul R, Norbury CF. Language disorders from infancy through adolescence. St. Louis (MO): Elsevier Health Sciences; 2012.
   Google Scholar
• Bloom L, Lahey M. Language development and language disorders. New York: John Willey & Sons; 1978.
   Google Scholar
• Karabekiroğlu K, H. Yöney “Integrative Processing of Internal and External Information & Implications for Autism” Türkiye’de Psikiyatri Dergisi, 2007;9(1): 58–65.
   Google Scholar
• Abu-Akel A “A neurobiological mapping of theory of mind” Brain Research Reviews 2003;43: 29–40.
   PubMed Web of Science ®Google Scholar
• Karabekiroğlu K, S. Akbaş. “Identifying and Differentiating PDD-NOS: A Comparison with Autism and ADHD” Yeni Symposium, 49(3), 141–152 (2011).
   Google Scholar
• American Psychiatric Assossiation (APA) (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington DC: American Psychiatric Association.
   Google Scholar
• Randell R, Somerville-Brown L, Chen W. How relevant is higher-order language deficit (HOLD) to children with complex presentations of attention-deficit hyperactivity disorder? Atten Defic Hyperact Disord. 2018. doi:10.1007/s12402-018-0279-4.
   Google Scholar
• Tien YM, Chen VC, Lo TS, Hsu CF, Gossop M, Huang KY. Deficits in auditory sensory discrimination among children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2018 Sep 18. doi:10.1007/s00787-018-1228-7.
   Google Scholar
• Green BC, Johnson KA, Bretherton L. Pragmatic language difficulties in children with hyperactivity and attention problems: an integrated review. Int J Lang Commun Disord. 2014;49(1):15–29.
   PubMed Web of Science ®Google Scholar
• Cohen NJ, Vallance DD, Barwick M, Im N, Menna R, Horodezky NB, Isaacson L. The interface between ADHD and language impairment:an examination of language, achievement, and cognitive processing. J Child Psychol Psychiatry. 2000;41(3):353–362.
   PubMed Web of Science ®Google Scholar
• Geurts HM, Embrechts M. Language profiles in ASD, SLI, and ADHD. Autism Dev Disord. 2008;38(10):1931–1943.
   PubMed Web of Science ®Google Scholar
• Phillips ML, Kupfer DJ. Bipolar disorder diagnosis: challenges and future directions. The Lancet. 2013;381 (9878):1663-71.
   Web of Science ®Google Scholar
• Wise T, Radua J, Nortje G, Cleare AJ, Young AH, Arnone D. Voxel-based meta-analytical evidence of structural disconnectivity in major depression and bipolar disorder. Biological psychiatry. 2016;79(4):293–302.
   PubMed Web of Science ®Google Scholar
• Repple J, Meinert S, Grotegerd D, Kugel H, Redlich R, Dohm K, et al. A voxel-based diffusion tensor imaging study in unipolar and bipolar depression. Bipolar disorders. 2017;19(1):23–31.
   PubMed Web of Science ®Google Scholar
• Fournier JC, Chase HW, Almeida J, Phillips ML. Within-and between-session changes in neural activity during emotion processing in unipolar and bipolar depression. Biological psychiatry: cognitive neuroscience and neuroimaging. 2016;1(6):518–527.
   Google Scholar
• Wu M-J, Wu HE, Mwangi B, Sanches M, Selvaraj S, Zunta-Soares GB, et al. Prediction of pediatric unipolar depression using multiple neuromorphometric measurements: a pattern classification approach. Journal of psychiatric research. 2015;62:84–91.
   PubMed Web of Science ®Google Scholar
• Han K-M, De Berardis D, Fornaro M, Kim Y-K. Differentiating between bipolar and unipolar depression in functional and structural MRI studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2018.
   Google Scholar
• Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2012;380(9859):2163–396.
   Web of Science ®Google Scholar
• Angold A, Costello EJ, Farmer EM, Burns BJ, Erkanli A. Impaired but undiagnosed. Journal of the American Academy of Child & Adolescent Psychiatry. 1999;38(2):129–137.
   PubMed Web of Science ®Google Scholar
• Musliner KL, Trabjerg BB, Waltoft BL, Laursen TM, Mortensen PB, Zandi PP, et al. Parental history of psychiatric diagnoses and unipolar depression: a Danish National Register-based cohort study. Psychological medicine. 2015;45(13):2781–2791.
   Web of Science ®Google Scholar
• Flint J, Kendler KS. The genetics of major depression. Neuron. 2014;81(3):484–503.
   PubMed Web of Science ®Google Scholar
• Thapar A, Collishaw S, Pine DS, Thapar AK. Depression in adolescence. The Lancet. 2012;379(9820):1056–367.
   Web of Science ®Google Scholar
• Rutter M, Kim-Cohen J, Maughan B. Continuities and discontinuities in psychopathology between childhood and adult life. Journal of Child Psychology and Psychiatry. 2006;47(3-4):276–95.
   Web of Science ®Google Scholar
• Etain B, Lajnef M, Bellivier F, Mathieu F, Raust A, Cochet B, et al. Clinical expression of bipolar disorder type I as a function of age and polarity at onset: convergent findings in samples from France and the United States. Journal of Clinical Psychiatry. 2012;73(4):e561–e566.
   PubMedGoogle Scholar
• Biederman J, Petty CR, Byrne D, Wong P, Wozniak J, Faraone SV. Risk for switch from unipolar to bipolar disorder in youth with ADHD: a long term prospective controlled study. Journal of affective disorders. 2009;119(1-3):16–21.
   PubMed Web of Science ®Google Scholar
• Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression: Possible implication for functional neuropathology. Br J Psychiatry 2001;178:200–206.
   PubMed Web of Science ®Google Scholar
• Thompson JM, Gallagher P, Hughes JH, Watson S, Gray JM, Ferrier IN. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005; 186: 32–40. 
   PubMed Web of Science ®Google Scholar
• Horn K, Roessner V, Holtmann M. Neurocognitive performance in children and adolescents with bipolar disorder: a review. Eur Child Adolesc Psychiatry. 2011;20(9):433- 450.
   PubMed Web of Science ®Google Scholar
• Doyle AE, Wilens TE, ve ark KA. Neuropsychological functioning in youth with bipolar disorder. Biol Psychiatry 2005;58:540–548.
   PubMed Web of Science ®Google Scholar
• Rucklidge RR (2006) Impact of ADHD on the neurocognitive functioning of adolescents with bipolar disorder. Biol Psychiatry 60:921–928.
   PubMed Web of Science ®Google Scholar
• Sole B, Bonnin CM, Torrent C, Martinez-Aran A, et. al. Neurocognitive Impairment Across the Bipolar Spectrum. CNS Neuroscience & Therapeutics, 2012; 18: 194–200.
   PubMed Web of Science ®Google Scholar
• John A. Sweeney, Julie A. Kmiec, and David J. Kupfer. Neuropsychologic Impairments in Bipolar and Unipolar Mood Disorders on the CANTAB Neurocognitive Battery. Biological Psychiatry, 2000; 48: 674–685.
   PubMed Web of Science ®Google Scholar
• Moreno C, Laje G, ve ark BC. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of general psychiatry 2007;64:1032–1039.
   PubMed Web of Science ®Google Scholar
• Strober M, Carlson G. Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three to four-year prospective follow-up investigation. Arch Gen Psychiatry 1982;39(5): 549–555.
   PubMedGoogle Scholar
• Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness: phenomenologic, familial, and pharmacologic predictors. J Affect Disord 1983;5(2):115–128.
   PubMed Web of Science ®Google Scholar
• Rao UMA, Ryan ND, Birmaher B, et al. Unipolar depression in adolescents: clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry 1995;34(5):566–578.
   PubMed Web of Science ®Google Scholar
• Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, Houck P, Ha W, Iyengar S, Kim E, Yen S, Hower H, EspositoSmythers C, Goldstein T, Ryan N, Keller M. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: The Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry 2009;166:795–804.
   PubMed Web of Science ®Google Scholar
• Goldstein I, Kim NN, Clayton AH, et al. Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review. Mayo Clin Proc. 2017;92(1):114–128.
   PubMed Web of Science ®Google Scholar
• Miller MK, Smith JR, Norman JJ, et al. Expert opinion on existing and developing drugs to treat female sexual dysfunction. Expert Opin Emerg Drugs. 2018;23(3):223–230.
   PubMed Web of Science ®Google Scholar
• Waldinger MD. Psychiatric disorders and sexual dysfunction. Handb Clin Neurol. 2015;130:469–489.
   PubMedGoogle Scholar
• Just MJ. The influence of atypical antipsychotic drugs on sexual function. Neuropsychiatr Dis Treat. 2015;11:1655–1661.
   PubMed Web of Science ®Google Scholar
• Montejo AL, Montejo L, Navarro-Cremades F. Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry. 2015;28(6):418–423.
   PubMed Web of Science ®Google Scholar
• Gross JJ. Emotion Regulation: Affective, Cognitive and Social Consequences. Psychophysiology 2002; 39: 281–291.
   PubMed Web of Science ®Google Scholar
• Wenar C, Kerig P. Developmental Psychopathology From Infancy Through Adolescence. 5th revised ed., McGraw Hill Higher Education; 2005, p. 696.
   Google Scholar
• Robbins TW, Sahakian BJ. Computer Methods of Assessment of Cognitive Function. In Copeland JRM, Abou-Saleh MT, Blazers DG, editors. Principles and Practice of Geriatric Psychiatry. Chichester: Wiley; 1994. p. 205–209.
   Google Scholar
• Geise C, Barzman D, Strakowski S. Pediatric Emotion Dysregulation : Biological and Developmental Evidence for a Dimensional Approach. The Psychiatric Quarterly 2014; 85(3): 383–389.
   Web of Science ®Google Scholar
• Ahmed SP, Bittencourt-Hewitt A, Sebastian CL. Neurocognitive Bases of Emotion Regulation Development in Adolescence.Developmental Cognitive Neuroscience 2015; 15: 11–25.
   PubMed Web of Science ®Google Scholar
• Beauchaine TP. Future Directions in Emotion Dysregulation and Youth Psychopathology. Journal of Clinical Child and Adolescent Psychology 2015; 44(5): 875–896.
   PubMed Web of Science ®Google Scholar
• McLaughlin KA, Hatzenbuehler ML, Mennin DS, Nolen-Hoeksema S. Emotion dysregulation and adolescent psychopathology: A prospective study. Behav Res Ther 2011;49(9):544–554.
   PubMed Web of Science ®Google Scholar
• Thompson RA, Calkins SD. The double-edged sword: Emotional regulation for children at risk. Dev Psychopathol 1996;8(01):163.
   Google Scholar
• Crowell SE, Beauchaine TP, Linehan MM. A biosocial developmental model of borderline personality: Elaborating and extending Linehan’s theory. Psychol Bull. 2009;135(3):495–510.
   PubMed Web of Science ®Google Scholar
• Desseilles M. et al. Cognitive and emotional processes during dreaming: A neuroimaging view. Consciousness and Cognition 20;2011:998–1008.
   PubMed Web of Science ®Google Scholar
• Domhoff GW, Fox KCR. Dreaming and the default network: A review, synthesis, and counterintuitive research proposal. Consciousness and Cognition 33;2015:342–353.
   PubMed Web of Science ®Google Scholar
• Siclari F. et al. The neural correlates of dreaming. Nat. Neurosci. 2017;20(6):872–878.
   PubMed Web of Science ®Google Scholar
• Wilson B, Butler LD. Running a gauntlet: A review of victimization and violence in the pre-entry, post-entry, and peri-/post-exit periods of commercial sexual exploitation. Psychological trauma: theory, research, practice, and policy 2014;6(5):494.
   Web of Science ®Google Scholar
• Nachar N, Lavoie ME, Marchand A, Guay S. The effect of talking about psychological trauma with a significant other on heart rate reactivity in individuals with posttraumatic stress disorder. Psychiatry research 2014;219(1):171–176.
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-5 diagnostic criteria for OCD disease. 1st ed. Washington (DC): American Psychiatric Association; 2013.
   Google Scholar
• Nazari H, Momeni N, Jariani M, Mohammad JT. Comparison of eye movement desensitization and reprocessing with citalopram in treatment of obsessive–compulsivedisorder. International Journal of Psychiatry in Clinical Practice 2011;15:270–274.
   PubMed Web of Science ®Google Scholar
• Steketee, G. Social support and treatment outcome of obsessive compulsive disorder at 9-month follow up. Behavioural and Cognitive Psychotherapy 1993;21:81–95.
   Web of Science ®Google Scholar
• Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain: a journal of neurology 1998;121(4):561–579.
   PubMed Web of Science ®Google Scholar
• Passarelli F, Donfrancesco R, Nativio P, Pascale E, Di Trani M, Patti AM, Villa MP. Anti-Purkinje cell antibody as a biological marker in attention deficit/hyperactivity disorder: a pilot study. Journal of neuroimmunology 2013;258(1):67–70.
   Web of Science ®Google Scholar
• Rapin L, Poissant H, Mendrek A. Atypical activations of fronto-cerebellar regions during forethought in parents of children with ADHD. Journal of attention disorders 2017;21(12):1050–1058.
   Web of Science ®Google Scholar
• Huguet G, Benabou M, Bourgeron T. The Genetics of Autism Spectrum Disorders, in A Time for Metabolism and Hormones. In Sassone-Corsi P, Christen Y, editors. Cham: Springer International Publishing; 2016, p. 101–129.
   Google Scholar
• Bowers K, Lin PI, Erickson C. Pharmacogenomic medicine in autism: challenges and opportunities. Paediatr Drugs 2015;17(2):115–124.
   Web of Science ®Google Scholar
• Vorstman JAS, et al., Autism genetics: opportunities and challenges for clinical translation. Nat Rev Genet 2017;18(6):362–376.
   Web of Science ®Google Scholar
• Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M, American Academy of Child. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2014;53(2): 237–257.
   PubMed Web of Science ®Google Scholar
• McGrew SG, Peters BR, Crittendon JA, Veenstra-VanderWeele J. Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement? Journal of autism and developmental disorders 2012;42(8):1582–1591.
   Web of Science ®Google Scholar
• AACAP. Prescribing psychoactive medication for children and adolescents. Am. Acad. Child Adolesc. Psychiatry. 2001.
   Web of Science ®Google Scholar
• Chen H, Patel A, Sherer J, Aparasu R. The definition and prevalence of pediatric psychotropic polypharmacy. Psychiatr Serv. 2011;62:1450–1455.
   Google Scholar
• Zonfrillo MR, Penn JV, Leonard HL. Pediatric psychotropic polypharmacy. Psychiatry (Edgmont). 2005;2:14–19.
   PubMedGoogle Scholar
• Fariz B. Psikiyatrik hastalıklar ve egzersiz Spor Hekimliği Dergisi 2015;50:131-38.
   Google Scholar
• Salzman C, Jeste DV, Meyer RE, Cohen-Mansfield J, Cum-mings J. Elderly patients with dementia-related symptoms of severe agitation and aggression: consen sus statement on treatment options, clinical trials met- hodology, and policy. J Clin Psychiatry. 2008;69(6):889–898.
   PubMed Web of Science ®Google Scholar
• Guallar-Castillon P, Bayan-Bravo A, Leon-Munoz LM, Balboa-Castillo T, Lopez- Garcia E, Gutierrez-Fisac JL, et al. The association of major patterns of physical activity, sedentary behavior and sleep with health-related quality of life: a cohort study. Preventive medicine 2014;67:248–254.
   Web of Science ®Google Scholar
• Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51(6):768–774.
   PubMed Web of Science ®Google Scholar
• Bayard S, Raffard S, Gely-Nargeot MC. Do facets of self-reported impulsivity predict decision-making under ambiguity and risk? Evidence from a community sample. Psychiatry Res. 2011;190(2–3):322–326.
   Web of Science ®Google Scholar
• Black RA, Serowik KL, Rosen MI. Associations between impulsivity and high risk sexual behaviors in dually diagnosed outpatients. Am J Drug Alcohol Abuse. 2009;35(5):325–328.
   PubMed Web of Science ®Google Scholar
• Heilbrun AB. Psychopathy and violent crime. J Consult Clin Psychol 1979; 47: 509–516.
   PubMed Web of Science ®Google Scholar
• Houston RJ, Stanford MS, Villemarette Pittman NR, Conklin SM, Helfritz LE. Neurobiological Correlates and Clinical Implications of Aggressive Subtypes. J Forensic Neuropsychol 2003;3:67–87.
   Google Scholar
• Nelson RJ, Trainor BC. Neural mechanisms of aggression. Nat Rev Neurosci 2007;8:536–546.
   PubMed Web of Science ®Google Scholar
• Kavoussi R, Armstead P, Coccaro E. The Neurobiology of Impulsive Aggression. Psychiatr Clin North Am 1997;20:395–403.
   PubMed Web of Science ®Google Scholar
• Coccaro EF, Fanning JR, Phan KL, Lee R. Serotonin and impulsive aggression. CNS Spectr 2015;20:295–302.
   PubMed Web of Science ®Google Scholar
• Blake P, Grafman J. The neurobiology of aggression. Lancet 2004;364:12–13.
   Web of Science ®Google Scholar
• Blair RJR. The Neurobiology of Impulsive Aggression. J Child Adolesc Psychopharmacol 2016;26:4–9.
   PubMed Web of Science ®Google Scholar
• Anderson CA, Bushman BJ. Human Aggression. Annu Rev Psychol 2002;53:27–51.
   PubMed Web of Science ®Google Scholar
• Pustilnik AC. Violence on the Brain: A Critique of Neuroscience in Criminal Law. Wake Forest Law Rev 2013;44:183–237.
   Google Scholar
• Gunn J, Taylor PJ. Forensic psychiatry: clinical, legal and ethical issues. 2nd ed. New York: CRC Press; 2014.
   Google Scholar
• Iglowstein I, Jenni OG, Molinari L, et al. Sleep duration from infancy to adolescence: reference values and generational trends. Pediatrics. 2003;111:302–307.
   PubMed Web of Science ®Google Scholar
• Mirmiran M, Maas YG, Ariagno RL. Development of fetal and neonatal sleep and circadian rhythms. Sleep Med Rev. 2003;7:321–334.
   PubMed Web of Science ®Google Scholar
• Mirmiran M, Lunshof S. Perinatal development of human circadian rhythms. Prog Brain Res. 1996;111:217–226.
   PubMed Web of Science ®Google Scholar
• Toptaş O, Akkaş İ, Özan F. Yanan Ağız Sendromu. Acta Odontol Turc 2014;31(2):102–105.
   Google Scholar
• Erdoğan B, Zorlu MY. Oral Hastalıklarda Güncel Tedavi: Yanan Ağız Sendromu, Türk Derm 2012; 46 Özel Sayı 2:119–122.
   Google Scholar
• Ritchie A, Kramer JM. Recent Advances in the Etiology and Treatment of Burning Mouth Syndrome J Dent Res 2018;97(11):1193–1199.
   Google Scholar
• Özen ME, Aydin M. Subjective halitosis: definition and classification. J N J Dent Assoc 2015;86(4):20–24.
   Google Scholar
• Aydin M, Derici MC, Yeler DY, et al. Criteria to distinguish subjective halitosis. Compend Contin Educ Dent 2017;38(10):e5–e8.
   Google Scholar
• Aydın M. Ağız kokusunu anlamak ve sınıflamak. Turkiye Klinikleri J Oral Maxillofac Surg-Special Topics 2016;2(1):5–16.
   Google Scholar
• Zaitsu T, Ueno M, Shinada K, et al. Social anxiety disorder in genuine halitosis patients. Health Qual Life Outcomes 2011;9:94.
   Web of Science ®Google Scholar
• Suzuki N, Yoneda M, Naito T, et al. Relationship between halitosis and psychologic status. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106(4):542–547.
   Web of Science ®Google Scholar
• Jastreboff MM, Jastreboff PJ. Components of decreased sound tolerance: hyperacusis, misophonia, phonophobia. ITHS News Lett. 2001; 2:5–7.
   Google Scholar
• Cavanna AE, Seri S. Misophonia: current perspectives. Neuropsychiatr Dis Treat. 2015; 11:2117–2123.
   PubMed Web of Science ®Google Scholar
• Dozier TH. Etiology, composition, development and maintenance of misophonia: a conditioned aversive reflex disorder. Psychological Thought. 2015; 8:114–129.
   Google Scholar
• Edelstein M, Brang D, Rouw R, Ramachandran VS. Misophonia: physiological investigations and case descriptions. Front Hum Neurosci. 2013; 7:296.
   Google Scholar
• Cavanna AE. What is misophonia and how can we treat it? Expert Rev Neurother. 2014;14:357–359.
   PubMed Web of Science ®Google Scholar
• Yıldız M, Kiras F, İncedere A, Esen D, Gürcan MB, Abut B, İpçi K, Tural Ü. Development of Social Functioning Assessment Scale (SFAS) for People with Schizophrenia: Validity and Reliability Study. Anadolu Psikiyatri Derg, 2018; 19(Suppl 2):29–38.
   Google Scholar
• Yildiz M, Erim R, Soygur H, Tural U, Kiras F, Gules E. Development and validation of the Subjective Recovery Assessment Scale for patients with schizophrenia. Psychiatry and Clinical Psychopharmacology 2018; 28(2):163–169.
   Web of Science ®Google Scholar
• Yildiz M, İncedere A, Kiras F, Abut FB, Kircali A, İpci K. Development of Self-Stigma Inventory for Families of the patients with schizophrenia (SSI-F): validity and reliability study. Psychiatry and Clinical Psychopharmacology 2018.
   Google Scholar
• Yildiz M, Kiras M, Incedere A, Abut FB. Development of self-stigma inventory for patients with schizophrenia (SSI-P): reliability and validity study. Psychiatry and Clinical Psychopharmacology, 2018.
   Google Scholar
• Markou, A. Neurobiology of nicotine dependence. Philosophical Transactions of the Royal Society B: Biological Sciences 2008;363(1507):3159–3168.
   Web of Science ®Google Scholar
• Stahl SM. Stahl’in Temel Psikofarmakolojisi. Tunç Alkın (Çeviri Ed.) 1.Baskı, İstanbul: İstanbul Tip Kitabevi, 2015; 547-551.
   Google Scholar
• Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 2001;24(2):97.
   PubMed Web of Science ®Google Scholar
• Türk Toraks Derneği Tütün Kontrolü Çalışma Grubu. Sigara Bırakma Tanı ve Tedavi Uzlaşı Raporu. Miki Matbaacılık, Ankara 2014.
   Google Scholar
• Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): A double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–2520.
   PubMed Web of Science ®Google Scholar
• Hurt RT, Ebbert JO, Croghan IT, Schroeder DR, Hurt RD, Hays JT. Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial. Drug Alcohol Depend [Internet]. 2018;184(October 2017):12–17.
   Google Scholar
• Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: An overview and network meta-analysis. Vol. 2013, Cochrane Database of Systematic Reviews. 2013.
   Google Scholar
• Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, Mecklenburg RE. Treating tobacco use and dependence: clinical practice guideline. Rockville (MD): US Department of Health and Human Services; 2000, 00-0032.
   Google Scholar
• WHO report on the global epidemic, 2008: The MPOWER package. Geneva, World Health Organization. 2008.
   Google Scholar
• Ryan F. Cognitive therapy for addiction: Motivation and change. John Wiley & Sons; 2012.
   Google Scholar
• Abdel-Haq R, Schlachetzki JC, Glass CK, Mazmanian SK. Microbiome–microglia connections via the gut–brain axis. J Exp Med 2019;216(1):41–59.
   PubMed Web of Science ®Google Scholar
• Sherwin E, Sandhu KV, Dinan TG, Cryan JF. May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry. CNS drugs 2016;30(11):1019–1041.
   PubMed Web of Science ®Google Scholar
• Sherwin E, Dinan TG, Cryan JF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann N Y Acad Sci 2017.
   PubMed Web of Science ®Google Scholar
• Walker EA, Katon WJ, Jemelka RP, Roy-Byrne PP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study. The American journal of medicine 1992;92(1):S26–S30.
   Google Scholar
• North CS, Alpers DH, Thompson SJ, Spitznagel EL. Gastrointestinal symptoms and psychiatric disorders in the general population, 1996.
   Google Scholar
• Haug TT, Mykletun A, Dahl AA. Are anxiety and depression related to gastrointestinal symptoms in the general population?. Scandinavian Journal of Gastroenterology 2002;37(3):294–298.
   PubMed Web of Science ®Google Scholar
• Mussell M, Kroenke K, Spitzer RL, Williams JB, Herzog W, Löwe B. Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety. Journal of psychosomatic research 2008;64(6):605–612.
   PubMed Web of Science ®Google Scholar
• Noyes R, Cook B, Garvey M, Summers R. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics, 1990; 31(1), 75–79.
   Web of Science ®Google Scholar
• Chami TN, Andersen AE, Crowell MD, et al. Gastrointestinal symptoms in bulimia nervosa: effects of treatment. Am J Gastroenterol. 1995;90:88–92.
   PubMed Web of Science ®Google Scholar
• Pamuk, Ö. N., Ümit, H., & Harmandar, O. (2009). Increased frequency of gastrointestinal symptoms in patients with fibromyalgia and associated factors: a comparative study. The Journal of rheumatology, jrheum-090024.
   Google Scholar
• Incidence of Gastrointestinal Symptoms in Children With Autism: A Population-Based Study Ibrahim SH, Voigt RG, Katusic SK, et al (Mayo Clinic, Rochester, MN) Pediatrics 124:680-686, 2009.
   Google Scholar
• North CS, Hong BA, Alpers DH. Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. World J Gastroenterol 2007;13(14):2020–2027.
   Web of Science ®Google Scholar
• Afari N, et al., Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis. Psychosom Med 2014;76(1):2–11.
   PubMed Web of Science ®Google Scholar
• Jones MP, et al., Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but Not in the Population. Clin Gastroenterol Hepatol 2017;15(7):1014–1020. e4.
   PubMed Web of Science ®Google Scholar
• Yanartas O, Kani HT, Bicakci E, Kilic I, Banzragch M, Acikel C, Atug O, Kuscu K, Imeryuz N, Akin H. The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease. Neuropsychiatr Dis Treat. 2016;12:673–683.
   PubMed Web of Science ®Google Scholar
• Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009;15(7):1105–1118.
   PubMed Web of Science ®Google Scholar
• Filipovic BR, Filipovic BF. Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol. 2014; 20(13):3552–3563.
   Web of Science ®Google Scholar
• American Psychiatric Association. Attention-deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders, 5th ed.. Arlington (VA): American Psychiatric Association, 2013. p. 59.
   Google Scholar
• Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich M, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011; 128:1007.
   Google Scholar
• Hammond DC. What is neurofeedback? Journal of neurotherapy 2007;10(4):25–36.
   Google Scholar
• American Psychiatric Association. Attention-deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders, 5th ed., Arlington (VA): American Psychiatric Association, 2013. p. 59.
   Google Scholar
• Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich M, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011; 128:1007.
   Google Scholar
• Applegate B, Lahey BB, Hart EL, et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry 1997; 36:1211.
   Web of Science ®Google Scholar
• Lahey BB, Applegate B, McBurnett K, et al. DSM-IV field trials for Attention-deficit/ hyperactivity disorder in children and adolescents. Am J Psychiatry 1994; 151:1673.
   Web of Science ®Google Scholar
• Kaneko, F., & Okamura, H. (2005). Study on the social maturity, self-perception, and associated factors, including motor coordination, of children with Attention-deficit/ hyperactivity disorder. Physical & Occupational Therapy in Pediatrics, 25(4) 2005.
   Google Scholar
• Wehmeier, P.M., Schacht, A., & Barkley, R.A. (2010). Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. Journal of Adolescent Health 46, 209–217.
   PubMed Web of Science ®Google Scholar
• Montoya A, Colom F, Ferrin M. Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review. Eur Psychiatry. 2011;26(3):166–175.
   PubMed Web of Science ®Google Scholar
• Van Den Hoofdakker BJ, Van der Veen-Mulders L, Sytema S, Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP, et al. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol. 2003;71(3):540.
   Web of Science ®Google Scholar
• Forehand R, Parent J, Sonuga-Barke E, Peisch VD, Long N, Abikoff HB. Which type of parent training works best for preschoolers with comorbid ADHD and ODD? A secondary analysis of a randomized controlled trial comparing generic and specialized programs. J Abnorm Child Psychol. 2016;44(8):1503–1513.
   Web of Science ®Google Scholar
• Schimmelmann BG, Schultze-Lutter F. Early detection and intervention of psychosis in children and adolescents: urgent need for studies, 2012.
   Google Scholar
• Schimmelmann BG, Conus P, Cotton S, McGorry PD, Lambert M. Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophrenia research 2007;95(1-3):1–8.
   PubMed Web of Science ®Google Scholar
• Amminger GP, Henry LP, Harrigan SM., Harris MG., Alvarez-Jimenez M, Herrman H, McGorry PD. Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study. Schizophrenia research 2011;131(1-3):112–119.
   PubMed Web of Science ®Google Scholar
• Amminger GP, Harris MG, Conus P, Lambert M, Elkins KS, Yuen HP, McGorry PD. Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000. Acta Psychiatrica Scandinavica 2006;114(5):337–345.
   PubMed Web of Science ®Google Scholar
• Nicolson R, Rapoport JL. Childhood-onset schizophrenia: rare but worth studying. Biol Psychiatry. 1999;46(10):1418–1428.
   Web of Science ®Google Scholar
• Stentebjerg-Olesen M, Pagsberg AK, Fink-Jensen A, Correll CU, Jeppesen P. Clinical Characteristics and Predictors of Outcome of Schizophrenia Spectrum Psychosis in Children and Adolescents: A Systematic Review. J Child Adolesc Psychopharmacol. 2016;26(5):410–427.
   Web of Science ®Google Scholar
• Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Schizophr Bull. 2011;37(1):21–22.
   PubMed Web of Science ®Google Scholar
• Jepsen JRM, Fagerlund B, Pagsberg AK, Christensen AMR, Hilker RW, Nordentoft M, Mortensen EL. Course of intelligence deficits in early onset, first episode schizophrenia: a controlled, 5-year longitudinal study. European child & adolescent psychiatry 2010;19(4):341- 351.
   Web of Science ®Google Scholar
• Iyer SN, Boekestyn L, Cassidy CM, King S, Joober R, Malla AK. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories. Psychological Medicine 2008;38(8):1147–1156.
   PubMed Web of Science ®Google Scholar
• Werry JS. Child and adolescent (early onset) schizophrenia: a review in light of DSM-III-R. Journal of Autism and Developmental Disorders 1992;22:601–624 114(5), 337-345.
   PubMed Web of Science ®Google Scholar
• Ballageer, T., Malla, A., Manchanda, R., Takhar, J., & Haricharan, R. (2005). Is adolescent-onset first-episode psychosis different from adult onset?. Journal of the American Academy of Child & Adolescent Psychiatry, 44(8), 782–789.
   PubMed Web of Science ®Google Scholar
• Joa, I., Johannessen, J. O., Langeveld, J., Friis, S., Melle, I., Opjordsmoen, S.,  …  & Larsen, T. K. (2009). Baseline profiles of adolescent vs. adult-onset first-episode psychosis in an early detection program. Acta Psychiatrica Scandinavica, 119(6), 494–500.
   PubMed Web of Science ®Google Scholar
• Durham, R. C., Guthrie, M., Morton, R. V., Reid, D. A., Treliving, L. R., Fowler, D., & MacDonald, R. R. (2003). Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms: results to 3-month follow-up. The British journal of psychiatry, 182(4), 303–311.
   Google Scholar
• Johannessen, J. O., Martindale, B. V., & Cullberg, J. (Eds.). (2007). Evolving psychosis: Different stages, different treatments. Routledge.
   Google Scholar
• Calaprice D, Tona J, Murphy TK. Treatment of pediatric acute-onset neuropsychiatric disorder in a large survey population. J Child Adolesc Psychopharmacol, Mar;28(2):92–103, 2018.
   Google Scholar
• Frankovich J, Swedo S, Murphy T, Dale RC, Agalliu D, Williams K, Daines M, Homig M, Chugani H, Sanger T, Muscal E, et al; Clinical management of pediatric acute-onset neuropsychiatric syndrome: part II-use of immunomodulatory therapies.  J Child Adolesc Psychopharmacol, 27(7):1–16, 2017.
   Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of first 50 cases. Am J Psychiatry, 155:264–271, 1998.
   PubMed Web of Science ®Google Scholar
• Thienemann M, Murphy T, Leckman J, et al. Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part I-Psychiatric and Behavioral Interventions. J Child Adolesc Psychopharmacol. Sep;27(7):566–573, 2017.
   PubMed Web of Science ®Google Scholar
• Wilbur C, Bitnun A, Kronenberg S, et al. PANDAS/PANS in childhood: Controversies and evidence. Paediatrics & Child Health pxy145, 2018.
   Google Scholar
• Baytunca, MB, Donuk T, ve Erermis S. Evaluation of a neuropsychiatric disorder: from PANDAS to PANS and CANS. Turk Psikiyatri Derg, 2016;27(2): 0
   Web of Science ®Google Scholar
• Greenberg R. How pediatric bipolar disorder and pandas/pans symptoms overlap and can cause diagnostic confusion. European Psychiatry 2013;1(1):2666. Abstracts of the 21th European Congress of Psychiatry. https://www.nimh.nih.gov/news/science-news/2017/guidelines-published-for-treating-pans-pandas.shtml
   Google Scholar
• Mink J, Kurlan R. Acute postinfectious movement and psychiatric disorders in children and adolescents. Journal of child neurology. Feb 2011;26(2):214–217.
   Web of Science ®Google Scholar
• Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. American Journal of Psychiatry. 1998;155(2):264–271.
   PubMed Web of Science ®Google Scholar
• Blakemore SJ, Choudhury S. Development of the adolescent brain: implications for executive function and social cognition. Journal of child psychology and psychiatry 2006;47(3-4):296–312.
   PubMed Web of Science ®Google Scholar
• Blakemore SJ. The social brain in adolescence. Nature Reviews Neuroscience 2008;9(4):267.
   PubMed Web of Science ®Google Scholar
• Choudhury S, Blakemore SJ Charman T. Social cognitive development during adolescence. Social cognitive and affective neuroscience 2006;1(3):165–174.
   PubMed Web of Science ®Google Scholar
• Bora E, Bartholomeusz C, Pantelis C. Meta-analysis of Theory of Mind (ToM) impairment in bipolar disorder. Psychological medicine 2016; 46(2):253–264.
   PubMed Web of Science ®Google Scholar
• Samamé C, Martino DJ, Strejilevich SA. Social cognition in euthymic bipolar disorder: systematic review and meta-analytic approach. Acta Psychiatrica Scandinavica 2012; 125(4):266–280.
   PubMed Web of Science ®Google Scholar
• Schenkel LS, Marlow-O'Connor M, Moss M, Sweeney JA, Pavuluri MN. Theory of mind and social inference in children and adolescents with bipolar disorder. Psychological Medicine 2008 ;38(6):791–800.
   PubMed Web of Science ®Google Scholar
• Wells A. Metacognitive Therapy for Anxiety and Depression. New York: Guilford Press; 2009. p. 1–3.
   Google Scholar
• Batmaz S, Kaymak SU, Kocbiyik S, et al. Metacognitions and emotional schemas: a new cognitive perspective for the distinction between unipolar and bipolar depression. Comprehensive Psychiatry. 2014;55:7:1546–1555.
   Web of Science ®Google Scholar
• Reilly-Harrington NA, Alloy LB, Fresco DM, et al. Cognitive styles and life events interact to predict bipolar and unipolar symptomatology. Journal of abnormal psychology 1999;108:4:567.
   Web of Science ®Google Scholar
• Barnard-Brak L, Roberts B, Valenzula E. Examining breaks and resistance in medication adherence among adolescents with ADHD as associated with school outcomes. J Atten Dis 2018 Mar 1: 1087054718763738.
   Google Scholar
• Shim SH, Yoon HJ, Hahn SW, Kim YK. Clinical and neurobiological factors in the management of treatment refractory Attention-deficit/ hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2016;70:237–244.
   Web of Science ®Google Scholar
• American Association of Psychiatry. Diagnostic and statistical manual of mental disorders 5th ed. Arlington (VA): American Psychiatric Publishing; 2013.
   Google Scholar
• Sareen J. Posttraumatic Stress Disorder in Adults: Impact, Comorbidity, Risk Factors, and Treatment. The Canadian Journal of Psychiatry 2014;59(9):460–467.
   PubMed Web of Science ®Google Scholar
• Schnyder UEA. Psychotherapies for PTSD: What do they have in common? European Journal of Psychotraumatology 2015;6(28186).
   Google Scholar
• Lahey BB, Schaughency E, Frame CL, Strauss CC. Teacher ratings of attention problems in children experimentally classified as exhibiting attention deficit disorders with and without hyperactivity. Journal of the American Academy of Child Psychiatry. 1985;24: 613–616.
   Google Scholar
• Milich R, Ballentine AC. Lynam ADHD/combined type and ADHD/predominantly inattentive type are distinct and unrelated disorders. Clinical Psychology: Science and Practice. 2001;8: 463–488.
   Web of Science ®Google Scholar
• McBurnett K, Pfiffner LJ, Frick PJ. Symptom properties as a function of ADHD type: an argument for continued study of sluggish cognitive tempo. Journal of Abnormal Child Psychology. 2001;29; 207–213.
   PubMed Web of Science ®Google Scholar
• Barkley RA. Distinguishing sluggish cognitive tempo from ADHD in children and adolescents: executive functioning, impairment, and comorbidity. Journal of Clinical Child and Adolescent Psychology. 2013;42: 161–173.
   PubMed Web of Science ®Google Scholar
• Marshall SA, Evans SW, Eiraldi RB, Becker SP, Power T J. Social and academic impairment in youth with ADHD, predominantly inattentive type and sluggish cognitive tempo. Journal of Abnormal Child Psychology. 2013;42; 77–90.
   Web of Science ®Google Scholar
• Becker SP, Burns GL, Leopold DR, et al. Differential impact of trait sluggish cognitive tempo and ADHD inattention in early childhood on adolescent functioning. J Child Psychol Psychiatry. 2018 Oct;59(10):1094–1104.
   PubMed Web of Science ®Google Scholar
• Baytunca MB, Inci SB, Ipci M, et al. The neurocognitive nature of children with ADHD comorbid sluggish cognitive tempo: Might SCT be a disorder of vigilance? Psychiatry Res. 2018 Dec;270:967–973.
   PubMed Web of Science ®Google Scholar
• Barkley RA. Distinguishing sluggish cognitive tempo from ADHD in children and adolescents: executive functioning, impairment, and comorbidity. J Clin Child Adolesc Psychol. 2013;42(2):161–173.
   PubMed Web of Science ®Google Scholar
• Becker, S. P., Leopold, D. R., Burns, G. L., Jarrett, M. A., Langberg, J. M., Marshall, S. A., … Willcutt, E. G. (2016). The Internal, External, and Diagnostic Validity of Sluggish Cognitive Tempo: A Meta-Analysis and Critical Review. J Am Acad Child Adolesc Psychiatry, 55(3), 163–178.
   PubMed Web of Science ®Google Scholar
• Camprodon-Rosanas E, Pujol J, Martínez-Vilavella G. Brain Structure and Function in School-Age Children With Sluggish Cognitive Tempo Symptoms. J Am Acad Child Adolesc Psychiatry. 2018;58
   Web of Science ®Google Scholar
• Fassbender C, Krafft CE, Schweitzer JB. Differentiating SCT and inattentive symptoms in ADHD using fMRI measures of cognitive control. Neuroimage Clin. 2015;8:390–397
   PubMed Web of Science ®Google Scholar
• Barkley Sluggish Cognitive Tempo Scale—Children and Adolescents (BSCTS-CA). Russell A. Barkley. Copyright © 2018. Guilford Publications.
   Google Scholar
• Barkley RA, DuPaul GJ, McMurray MB. Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate. Pediatrics, 1991;87(4):519–531.
   PubMed Web of Science ®Google Scholar
• Froehlich TE, Becker SP, Nick TG, Brinkman WB, Stein MA, Peugh J, Epstein JN. Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial. J Clin Psychiatry, 2018;79(2). pii: 17m11553.
   Web of Science ®Google Scholar
• Wietecha L, Williams D, Shaywitz S, Shaywitz B, Hooper SR, Wigal SB, Dunn D, McBurnett K. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial. J Child Adolesc Psychopharmacol. 2013; 23(9):605–613.
   Web of Science ®Google Scholar
• First MB. “Diagnostic and statistical manual of mental disorders,” DSM IV-4th edition. APA, p. 1994, 1994.
   Google Scholar
• Kanade T, Cohn JF, Tian Y. “Comprehensive database for facial expression analysis,” in Automatic Face and Gesture Recognition, 2000. Proceedings. Fourth IEEE International Conference on. IEEE, 2000, pp. 46–53.
   Google Scholar
• Kononenko I, ˇSimec E, Robnik-ˇ Sikonja M. Overcoming the myopia of inductive learning algorithms with RELIEFF. Applied Intelligence 1997;7(1):39–55.
   Web of Science ®Google Scholar
• Gioia GA, et al. Test review behavior rating inventory of executive function. Child Neuropsychology. 2000;6(3):235–238.
   PubMed Web of Science ®Google Scholar
• Barkley RA. ADHD and the nature of self-control. Guilford Press; 1997.
   Google Scholar
• Rensink RA, O’Regan JK, Clark JJ. To see or not to see: The need for attention to perceive changes in scenes. Psychological science. 1997;8(5):368–373.
   Web of Science ®Google Scholar
• Cohen AL. Performance on the flicker task and Conners CPT in children with ADHD. Auburn: Auburn University; 2009.
   Google Scholar
• Sonuga-Barke EJ, Elgie S, Hall M. More to ADHD than meets the eye: observable abnormalities in search behaviour do not account for performance deficits on a discrimination task. Behavioral and brain functions. 2005;1(1):1.
   Google Scholar